Title
Category
Credits
Event date
Cost
  • Research to Practice
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Thoracic surgery is an integral part of the multidisciplinary management of patients with lung cancer. This lecture discusses approaches to lung tumor resection and areas of future investigation in treatment of advanced lung cancer.
  • Patient Centered Care
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Cancer and cancer treatments can affect patient’s memory, concentration, and other aspects of cognition. While this condition is often called ‘chemo-brain,’ cognitive dysfunction can be due to many factors in patients with cancer. Dr. Nakamura will review our latest understandings of this condition.
  • Patient Centered Care
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
More than ever before, there are rising cases of colon and rectal cancers among young people.  Updated recommendations have lowered the age of screening to age 45 from standard age of 50.
  • Research to Practice
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
A comprehensive overview of past, present, and future management of systemic therapy for muscle-invasive bladder cancer and renal cell carcinoma. Includes updates on neoadjuvant and adjuvant therapy, as well as organ preservation techniques.
  • Research to Practice
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Shetal A. Patel, MD, PhD will provide an update on recent data impacting the management of lung cancer.
  • Patient Centered Care
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Testicular cancer is the most common cancer in young men. We will discuss different aspects of this cancer from diagnosis, treatment options, and post-treatment survivorship.
  • Research to Practice
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.
  • Patient Centered Care
  • Southeastern American Indian Cancer Health Equity Partnership
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Ronny Bell, PhD, MS, and Marc Emerson, PhD, MPH, in this collaborative session will provide context regarding the cancer disparities and efforts to address these disparities for American Indians and Alaska Natives across the US. Dr. Bell will provide context for understanding and addressing cancer disparities among American Indians in North Carolina.
  • Patient Centered Care
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
In this webinar, we will discuss the definition and use of electronic patient-reported outcomes (ePROs) and mobile health technology in optimizing postoperative cancer care.
  • Research to Practice
  • ACPE Pharmacist
  • ACPE Pharmacy Tech
  • ASRT
  • CTR
  • NCPD/CNE
  • Participation
$0.00
Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture will discuss several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more.

Pages